Italy Tumor Markers Sales Segment Forecasts for over 40 Tests: 2019 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 9, 2020--
The “Italy Tumor Markers Sales Segment Forecasts for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities” report has been added to ResearchAndMarkets.com’s offering.
The author’s new report is a study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Italy Market Overview
Business Opportunities and Strategic Recommendations
Over 200 Current and Emerging Cancer Diagnostic Test
Supplier Shares, Sales and Volume Forecasts
chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologies and their potential applications for cancer diagnostic testing.
The companies analyzed in the report include:
For more information about this report visit https://www.researchandmarkets.com/r/fu8gih
View source version on businesswire.com:https://www.businesswire.com/news/home/20200109005372/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: ITALY EUROPE
INDUSTRY KEYWORD: HEALTH ONCOLOGY MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 01/09/2020 06:10 AM/DISC: 01/09/2020 06:10 AM